Corcym is touting positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve in its MANTRA ...

Corcym's Perceval Plus sutureless aortic heart valve shows excellent durability, safety and quality of life at up to 7 years at EACTS meeting.

Edwards Lifesciences (NYSE:EW) benefits from expanded Medicare coverage for TAVR and a structural heart deal, keeping the healthcare device maker in focus.

Hospitals are listed alphabetically within each tier. Measures beyond those shown in the tables were used to evaluate hospitals (see “About This List” at the bottom of the article). The patient safety ...

Deborah Heart and Lung Center performed its first commercial implant of the Trilogy Transcatheter Heart Valve (THV) System ...

Current replacement heart valves come with significant limitations. Mechanical valves typically require patients to take blood-thinning medications for life, while bioprosthetic valves, often made ...

Boost ROI by targeting mitral, tricuspid and LAA closure innovations, expanding clinical indications, and pursuing startup acquisitions and imaging partnerships.Dublin, Oct. 06, 2026 (GLOBE NEWSWIRE) ...

Updated clinical practice guidelines outline new protocols for cardiovascular risk assessment and medical therapy prior to noncardiac surgery.

From cutting heart valves without open-heart surgery to confronting Israel’s growing medical brain drain, Sheba cardiologist ...

Latifi’s lab, which is a joint program between USF Health and the College of Engineering, is developing tissue-engineered heart valves that combine advanced biomaterials with a patient’s own cells.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® ...

The natural history of symptomatic severe aortic stenosis (AS) heralds a poor prognosis—a paradigm that rightly drives valve ...